InsiderClue
Insiders · Profile

Flynn James E

Director at Larimar Therapeutics · 10% owner at ARS Pharmaceuticals · 10% owner at Bicara Therapeutics · and 30 more. Filing since 13 Nov 2008. CIK 0001352546

LRMR Larimar Therapeutics, Inc. Director · 22 trades SPRY ARS Pharmaceuticals, Inc. 10% owner · 3 trades BCAX Bicara Therapeutics Inc. 10% owner · 1 trade AHCO AdaptHealth Corp. 10% owner · 4 trades MIRM Mirum Pharmaceuticals, Inc. 10% owner · 6 trades PEPG PepGen Inc. 10% owner · 1 trade XLO Xilio Therapeutics, Inc. 10% owner · 1 trade HOWL Werewolf Therapeutics, Inc. 10% owner · 1 trade EWTX Edgewise Therapeutics, Inc. 10% owner · 1 trade CALC CalciMedica, Inc. 10% owner · 1 trade ANNX Annexon, Inc. 10% owner · 2 trades NKTX Nkarta, Inc. 10% owner · 2 trades RVMD Revolution Medicines, Inc. 10% owner · 1 trade SDGR Schrodinger, Inc. 10% owner · 1 trade BDTX Black Diamond Therapeutics, Inc. 10% owner · 1 trade FIXX Q32 Bio Inc. 10% owner · 16 trades CABA Cabaletta Bio, Inc. 10% owner · 1 trade KRRO Korro Bio, Inc. 10% owner · 1 trade ACRS Aclaris Therapeutics, Inc. 10% owner · 14 trades ARVN ARVINAS, INC. 10% owner · 3 trades KNSA Kiniksa Pharmaceuticals International, plc 10% owner · 1 trade GYRE GYRE THERAPEUTICS, INC. 10% owner · 3 trades TARA Protara Therapeutics, Inc. Director · 5 trades RYTM RHYTHM PHARMACEUTICALS, INC. 10% owner · 1 trade EHTH eHealth, Inc. 10% owner · 41 trades VNDA Vanda Pharmaceuticals Inc. 10% owner · 29 trades AXGN Axogen, Inc. 10% owner · 6 trades EDIT Editas Medicine, Inc. 10% owner · 1 trade CTMX CytomX Therapeutics, Inc. 10% owner · 2 trades RGNX REGENXBIO Inc. 10% owner · 3 trades ATYR aTYR PHARMA INC 10% owner · 2 trades RIGL RIGEL PHARMACEUTICALS INC 10% owner · 8 trades BGMS Bio Green Med Solution, Inc. 10% owner · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
LRMR Larimar Therapeutics, Inc.
27 Feb 2026
Director
Bought
5,000,000
$25.00M
88.9%
LRMR Larimar Therapeutics, Inc.
31 Jul 2025
Director
Bought
9,375,000
$30.00M
×57
SPRY ARS Pharmaceuticals, Inc.
27 Jun 2025
10% owner
Sold at will
740,149
$13.66M
13.2%
SPRY ARS Pharmaceuticals, Inc.
12 Nov 2024
10% owner
Sold at will
34,814
$609.06K
0.7%
SPRY ARS Pharmaceuticals, Inc.
11 Nov 2024
10% owner
Sold at will
528,456
$9.53M
9.1%
BCAX Bicara Therapeutics Inc.
17 Sep 2024
10% owner
Bought
70,000
$1.26M
8.5%
AHCO AdaptHealth Corp.
12 Mar 2024
10% owner
Sold at will
114,906
$1.23M
1.0%
AHCO AdaptHealth Corp.
11 Mar 2024
10% owner
Sold at will
182,607
$2.01M
1.5%
AHCO AdaptHealth Corp.
8 Mar 2024
10% owner
Sold at will
52,487
$573.65K
0.4%
LRMR Larimar Therapeutics, Inc.
16 Feb 2024
Director
Bought
4,290,617
$37.50M
231%
LRMR Larimar Therapeutics, Inc.
16 Sep 2022
Director
Bought
11,111,108
$35.00M
opened
MIRM Mirum Pharmaceuticals, Inc.
6 Jun 2022
10% owner
Sold, plan not stated
38,478
$962.26K
2.4%
PEPG PepGen Inc.
10 May 2022
10% owner
Bought
416,666
$5.00M
693%
XLO Xilio Therapeutics, Inc.
26 Oct 2021
10% owner
Bought
775,000
$12.40M
210%
MIRM Mirum Pharmaceuticals, Inc.
9 Jul 2021
10% owner
Sold, plan not stated
99,325
$1.57M
100%
MIRM Mirum Pharmaceuticals, Inc.
7 Jul 2021
10% owner
Sold, plan not stated
6,837
$108.50K
6.4%
MIRM Mirum Pharmaceuticals, Inc.
6 Jul 2021
10% owner
Sold, plan not stated
49,239
$797.43K
31.7%
MIRM Mirum Pharmaceuticals, Inc.
2 Jul 2021
10% owner
Sold, plan not stated
10,599
$180.30K
6.4%
LRMR Larimar Therapeutics, Inc.
30 Jun 2021
Director
Bought
228,571
$2.00M
13.3%
LRMR Larimar Therapeutics, Inc.
30 Jun 2021
Director
Bought
228,570
$2.00M
13.3%
LRMR Larimar Therapeutics, Inc.
30 Jun 2021
Director
Bought
228,569
$2.00M
13.3%
HOWL Werewolf Therapeutics, Inc.
4 May 2021
10% owner
Bought
800,000
$12.80M
45.6%
EWTX Edgewise Therapeutics, Inc.
30 Mar 2021
10% owner
Bought
625,000
$10.00M
18.9%
CALC CalciMedica, Inc.
29 Sep 2020
10% owner
Bought
1,562,500
$25.00M
536%
ANNX Annexon, Inc.
28 Jul 2020
10% owner
Bought
350,000
$5.95M
76.3%
ANNX Annexon, Inc.
28 Jul 2020
10% owner
Bought
350,000
$5.95M
76.3%
NKTX Nkarta, Inc.
14 Jul 2020
10% owner
Bought
500,000
$9.00M
70.4%
NKTX Nkarta, Inc.
14 Jul 2020
10% owner
Bought
500,000
$9.00M
70.4%
RVMD Revolution Medicines, Inc.
18 Feb 2020
10% owner
Bought
600,000
$10.20M
86.0%
SDGR Schrodinger, Inc.
10 Feb 2020
10% owner
Bought
250,000
$4.25M
opened
BDTX Black Diamond Therapeutics, Inc.
3 Feb 2020
10% owner
Bought
400,000
$7.60M
106%
FIXX Q32 Bio Inc.
30 Jan 2020
10% owner
Sold, plan not stated
509,970
$7.88M
100%
FIXX Q32 Bio Inc.
29 Jan 2020
10% owner
Sold, plan not stated
8,857
$136.81K
1.7%
FIXX Q32 Bio Inc.
28 Jan 2020
10% owner
Sold, plan not stated
65,891
$1.02M
11.3%
FIXX Q32 Bio Inc.
27 Jan 2020
10% owner
Sold, plan not stated
193,359
$3.05M
24.9%
FIXX Q32 Bio Inc.
24 Jan 2020
10% owner
Sold, plan not stated
380,256
$5.96M
32.8%
FIXX Q32 Bio Inc.
24 Dec 2019
10% owner
Sold, plan not stated
198,767
$4.36M
7.9%
FIXX Q32 Bio Inc.
24 Dec 2019
10% owner
Sold, plan not stated
151,233
$3.32M
7.9%
FIXX Q32 Bio Inc.
23 Dec 2019
10% owner
Sold, plan not stated
74,384
$1.62M
2.9%
FIXX Q32 Bio Inc.
23 Dec 2019
10% owner
Sold, plan not stated
56,595
$1.24M
2.9%
FIXX Q32 Bio Inc.
20 Dec 2019
10% owner
Sold, plan not stated
11,999
$257.98K
0.5%
FIXX Q32 Bio Inc.
20 Dec 2019
10% owner
Sold, plan not stated
9,130
$196.30K
0.5%
FIXX Q32 Bio Inc.
19 Dec 2019
10% owner
Sold, plan not stated
7,168
$155.37K
0.3%
FIXX Q32 Bio Inc.
19 Dec 2019
10% owner
Sold, plan not stated
5,454
$118.22K
0.3%
CABA Cabaletta Bio, Inc.
29 Oct 2019
10% owner
Bought
700,000
$7.70M
opened
KRRO Korro Bio, Inc.
7 Oct 2019
10% owner
Bought
285,714
$4.00M
opened
MIRM Mirum Pharmaceuticals, Inc.
22 Jul 2019
10% owner
Bought
332,000
$4.98M
23.8%
ACRS Aclaris Therapeutics, Inc.
27 Jun 2019
10% owner
Sold, plan not stated
590,801
$1.59M
15.8%
ACRS Aclaris Therapeutics, Inc.
27 Jun 2019
10% owner
Sold, plan not stated
108,674
$292.41K
10.1%
ACRS Aclaris Therapeutics, Inc.
26 Jun 2019
10% owner
Sold, plan not stated
1,352
$6.09K
0.0%
ACRS Aclaris Therapeutics, Inc.
26 Jun 2019
10% owner
Sold, plan not stated
352
$1.58K
0.0%
ACRS Aclaris Therapeutics, Inc.
25 Jun 2019
10% owner
Sold, plan not stated
40,850
$184.19K
1.1%
ACRS Aclaris Therapeutics, Inc.
25 Jun 2019
10% owner
Sold, plan not stated
10,634
$47.95K
1.0%
ACRS Aclaris Therapeutics, Inc.
24 Jun 2019
10% owner
Sold, plan not stated
50,177
$226.93K
1.3%
ACRS Aclaris Therapeutics, Inc.
24 Jun 2019
10% owner
Sold, plan not stated
13,063
$59.08K
1.2%
ACRS Aclaris Therapeutics, Inc.
21 Jun 2019
10% owner
Sold, plan not stated
269,402
$1.24M
6.6%
ACRS Aclaris Therapeutics, Inc.
21 Jun 2019
10% owner
Sold, plan not stated
70,135
$323.70K
6.0%
ACRS Aclaris Therapeutics, Inc.
10 May 2019
10% owner
Sold, plan not stated
108,696
$657.52K
2.6%
ACRS Aclaris Therapeutics, Inc.
10 May 2019
10% owner
Sold, plan not stated
71,869
$434.75K
5.8%
ACRS Aclaris Therapeutics, Inc.
9 May 2019
10% owner
Sold, plan not stated
261,345
$1.61M
5.8%
ACRS Aclaris Therapeutics, Inc.
9 May 2019
10% owner
Sold, plan not stated
172,800
$1.06M
12.2%
FIXX Q32 Bio Inc.
12 Apr 2019
Director
Bought
533,333
$12.00M
85.3%
ARVN ARVINAS, INC.
1 Oct 2018
10% owner
Bought
104,167
$1.67M
33.9%
ARVN ARVINAS, INC.
1 Oct 2018
10% owner
Bought
104,167
$1.67M
33.9%
ARVN ARVINAS, INC.
1 Oct 2018
10% owner
Bought
104,166
$1.67M
33.9%
KNSA Kiniksa Pharmaceuticals International, plc
29 May 2018
10% owner
Bought
843,352
$16.00M
opened
FIXX Q32 Bio Inc.
2 Apr 2018
Director
Bought
625,000
$10.00M
31.4%
FIXX Q32 Bio Inc.
2 Apr 2018
Director
Bought
625,000
$10.00M
opened
GYRE GYRE THERAPEUTICS, INC.
8 Mar 2018
10% owner
Sold, plan not stated
9,317
$271.63K
0.8%
GYRE GYRE THERAPEUTICS, INC.
7 Mar 2018
10% owner
Sold, plan not stated
10,000
$300.00K
0.9%
GYRE GYRE THERAPEUTICS, INC.
6 Mar 2018
10% owner
Sold, plan not stated
52,461
$1.62M
4.4%
AHCO AdaptHealth Corp.
21 Feb 2018
Director
Bought
2,500,000
no price
opened
TARA Protara Therapeutics, Inc.
30 Nov 2017
Director
Bought
110,557
$193.47K
127%
TARA Protara Therapeutics, Inc.
30 Nov 2017
Director
Sold, plan not stated
110,557
$193.47K
100%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
10% owner
Bought
355,000
$6.04M
313%
EHTH eHealth, Inc.
27 Apr 2017
10% owner
Sold, plan not stated
183,805
$2.15M
42.9%
EHTH eHealth, Inc.
27 Apr 2017
10% owner
Sold, plan not stated
71,837
$841.21K
7.6%
EHTH eHealth, Inc.
27 Apr 2017
10% owner
Sold, plan not stated
58,067
$679.96K
7.6%
EHTH eHealth, Inc.
26 Apr 2017
10% owner
Sold, plan not stated
66,351
$764.36K
13.4%
EHTH eHealth, Inc.
26 Apr 2017
10% owner
Sold, plan not stated
25,932
$298.74K
2.7%
EHTH eHealth, Inc.
26 Apr 2017
10% owner
Sold, plan not stated
20,962
$241.48K
2.7%
EHTH eHealth, Inc.
13 Apr 2017
10% owner
Sold, plan not stated
87,886
$966.75K
15.1%
EHTH eHealth, Inc.
13 Apr 2017
10% owner
Sold, plan not stated
34,349
$377.84K
3.4%
EHTH eHealth, Inc.
13 Apr 2017
10% owner
Sold, plan not stated
27,765
$305.42K
3.4%
EHTH eHealth, Inc.
11 Apr 2017
10% owner
Sold, plan not stated
19,593
$215.77K
3.3%
EHTH eHealth, Inc.
11 Apr 2017
10% owner
Sold, plan not stated
7,658
$84.33K
0.8%
EHTH eHealth, Inc.
11 Apr 2017
10% owner
Sold, plan not stated
6,189
$68.16K
0.8%
EHTH eHealth, Inc.
10 Apr 2017
10% owner
Sold, plan not stated
46,730
$515.78K
7.2%
EHTH eHealth, Inc.
10 Apr 2017
10% owner
Sold, plan not stated
18,264
$201.59K
1.8%
EHTH eHealth, Inc.
10 Apr 2017
10% owner
Sold, plan not stated
14,763
$162.95K
1.8%
EHTH eHealth, Inc.
7 Apr 2017
10% owner
Sold, plan not stated
69,667
$816.24K
9.7%
EHTH eHealth, Inc.
7 Apr 2017
10% owner
Sold, plan not stated
27,228
$319.01K
2.6%
EHTH eHealth, Inc.
7 Apr 2017
10% owner
Sold, plan not stated
22,009
$257.86K
2.6%
VNDA Vanda Pharmaceuticals Inc.
23 Sep 2016
10% owner
Sold, plan not stated
348,258
$5.82M
14.6%
VNDA Vanda Pharmaceuticals Inc.
23 Sep 2016
10% owner
Sold, plan not stated
273,632
$4.57M
14.6%
VNDA Vanda Pharmaceuticals Inc.
23 Sep 2016
10% owner
Sold, plan not stated
157,607
$2.63M
18.5%
VNDA Vanda Pharmaceuticals Inc.
22 Sep 2016
10% owner
Sold, plan not stated
152,334
$2.47M
6.0%
VNDA Vanda Pharmaceuticals Inc.
22 Sep 2016
10% owner
Sold, plan not stated
119,690
$1.94M
6.0%
VNDA Vanda Pharmaceuticals Inc.
22 Sep 2016
10% owner
Sold, plan not stated
68,940
$1.12M
7.5%
VNDA Vanda Pharmaceuticals Inc.
19 Sep 2016
10% owner
Sold, plan not stated
37,044
$577.15K
3.9%
VNDA Vanda Pharmaceuticals Inc.
19 Sep 2016
10% owner
Sold, plan not stated
4,910
$76.24K
0.2%
VNDA Vanda Pharmaceuticals Inc.
19 Sep 2016
10% owner
Sold, plan not stated
3,857
$59.89K
0.2%
VNDA Vanda Pharmaceuticals Inc.
16 Sep 2016
10% owner
Sold, plan not stated
119,008
$1.86M
4.5%
VNDA Vanda Pharmaceuticals Inc.
16 Sep 2016
10% owner
Sold, plan not stated
93,506
$1.46M
4.5%
VNDA Vanda Pharmaceuticals Inc.
16 Sep 2016
10% owner
Sold, plan not stated
87,858
$1.37M
8.4%
VNDA Vanda Pharmaceuticals Inc.
15 Sep 2016
10% owner
Sold, plan not stated
79,915
$1.26M
2.9%
VNDA Vanda Pharmaceuticals Inc.
15 Sep 2016
10% owner
Sold, plan not stated
62,791
$989.27K
2.9%
VNDA Vanda Pharmaceuticals Inc.
15 Sep 2016
10% owner
Sold, plan not stated
58,997
$929.50K
5.3%
AXGN Axogen, Inc.
21 Jul 2016
10% owner
Sold, plan not stated
102,136
$684.31K
3.3%
LRMR Larimar Therapeutics, Inc.
20 Jul 2016
10% owner
Sold, plan not stated
901,430
$2.99M
43.9%
LRMR Larimar Therapeutics, Inc.
20 Jul 2016
10% owner
Sold, plan not stated
246,439
$816.16K
43.9%
LRMR Larimar Therapeutics, Inc.
20 Jul 2016
10% owner
Sold, plan not stated
193,630
$641.26K
43.9%
AXGN Axogen, Inc.
18 Jul 2016
10% owner
Sold, plan not stated
41,425
$284.59K
1.3%
AXGN Axogen, Inc.
15 Jul 2016
10% owner
Sold, plan not stated
31,788
$232.69K
1.0%
AXGN Axogen, Inc.
14 Jul 2016
10% owner
Sold, plan not stated
206,090
$1.59M
6.1%
EHTH eHealth, Inc.
21 Jun 2016
10% owner
Sold, plan not stated
26,400
$377.55K
3.5%
EHTH eHealth, Inc.
20 Jun 2016
10% owner
Sold, plan not stated
178,454
$2.53M
19.3%
EHTH eHealth, Inc.
14 Jun 2016
10% owner
Sold, plan not stated
43,300
$601.17K
4.5%
EHTH eHealth, Inc.
8 Jun 2016
10% owner
Sold, plan not stated
28,080
$388.63K
2.8%
EHTH eHealth, Inc.
7 Jun 2016
10% owner
Sold, plan not stated
7,154
$99.38K
0.7%
EHTH eHealth, Inc.
6 Jun 2016
10% owner
Sold, plan not stated
28,502
$399.04K
2.8%
EHTH eHealth, Inc.
2 Jun 2016
10% owner
Sold, plan not stated
42,668
$591.74K
4.0%
EHTH eHealth, Inc.
1 Jun 2016
10% owner
Sold, plan not stated
5
$69.00
0.0%
EHTH eHealth, Inc.
31 May 2016
10% owner
Sold, plan not stated
56,835
$786.62K
5.0%
EHTH eHealth, Inc.
27 May 2016
10% owner
Sold, plan not stated
72,649
$1.02M
6.0%
EHTH eHealth, Inc.
26 May 2016
10% owner
Sold, plan not stated
93,965
$1.33M
7.2%
EHTH eHealth, Inc.
25 May 2016
10% owner
Sold, plan not stated
45,967
$655.17K
3.4%
LRMR Larimar Therapeutics, Inc.
12 Feb 2016
10% owner
Bought
28,377
$177.26K
5.3%
LRMR Larimar Therapeutics, Inc.
12 Feb 2016
10% owner
Bought
22,296
$139.27K
5.3%
LRMR Larimar Therapeutics, Inc.
12 Feb 2016
10% owner
Bought
13,872
$86.65K
0.7%
LRMR Larimar Therapeutics, Inc.
11 Feb 2016
10% owner
Bought
1,030
$6.37K
0.2%
LRMR Larimar Therapeutics, Inc.
11 Feb 2016
10% owner
Bought
810
$5.01K
0.2%
LRMR Larimar Therapeutics, Inc.
11 Feb 2016
10% owner
Bought
504
$3.12K
0.0%
LRMR Larimar Therapeutics, Inc.
10 Feb 2016
10% owner
Bought
66,486
$414.36K
14.3%
LRMR Larimar Therapeutics, Inc.
10 Feb 2016
10% owner
Bought
52,239
$325.57K
14.3%
LRMR Larimar Therapeutics, Inc.
10 Feb 2016
10% owner
Bought
32,501
$202.56K
1.6%
LRMR Larimar Therapeutics, Inc.
9 Feb 2016
10% owner
Bought
50,086
$286.95K
12.1%
LRMR Larimar Therapeutics, Inc.
9 Feb 2016
10% owner
Bought
39,353
$225.46K
12.1%
LRMR Larimar Therapeutics, Inc.
9 Feb 2016
10% owner
Bought
24,484
$140.27K
1.2%
EDIT Editas Medicine, Inc.
8 Feb 2016
10% owner
Bought
100,000
$1.60M
11.7%
VNDA Vanda Pharmaceuticals Inc.
16 Dec 2015
10% owner
Bought
4,441
$39.82K
0.2%
VNDA Vanda Pharmaceuticals Inc.
16 Dec 2015
10% owner
Bought
3,490
$31.29K
0.2%
VNDA Vanda Pharmaceuticals Inc.
16 Dec 2015
10% owner
Bought
3,239
$29.04K
0.3%
VNDA Vanda Pharmaceuticals Inc.
11 Dec 2015
10% owner
Bought
128,374
$1.11M
4.9%
VNDA Vanda Pharmaceuticals Inc.
11 Dec 2015
10% owner
Bought
100,864
$868.33K
4.9%
VNDA Vanda Pharmaceuticals Inc.
11 Dec 2015
10% owner
Bought
93,634
$806.09K
9.3%
VNDA Vanda Pharmaceuticals Inc.
10 Dec 2015
10% owner
Bought
40,997
$352.17K
2.0%
VNDA Vanda Pharmaceuticals Inc.
10 Dec 2015
10% owner
Bought
32,211
$276.70K
1.3%
VNDA Vanda Pharmaceuticals Inc.
10 Dec 2015
10% owner
Bought
29,902
$256.86K
3.1%
VNDA Vanda Pharmaceuticals Inc.
9 Dec 2015
10% owner
Bought
308,290
$2.54M
13.7%
VNDA Vanda Pharmaceuticals Inc.
9 Dec 2015
10% owner
Bought
242,228
$2.00M
13.7%
VNDA Vanda Pharmaceuticals Inc.
9 Dec 2015
10% owner
Bought
224,864
$1.86M
29.9%
CTMX CytomX Therapeutics, Inc.
14 Oct 2015
10% owner
Bought
510,512
$6.13M
318%
CTMX CytomX Therapeutics, Inc.
14 Oct 2015
10% owner
Bought
114,488
$1.37M
71.3%
RGNX REGENXBIO Inc.
22 Sep 2015
10% owner
Bought
87,500
$1.93M
7.5%
RGNX REGENXBIO Inc.
22 Sep 2015
10% owner
Bought
49,000
$1.08M
opened
RGNX REGENXBIO Inc.
22 Sep 2015
10% owner
Bought
38,500
$847.00K
opened
AXGN Axogen, Inc.
18 Sep 2015
10% owner
Sold, plan not stated
345,000
$1.90M
9.3%
ATYR aTYR PHARMA INC
12 May 2015
10% owner
Bought
25,000
$350.00K
10.8%
ATYR aTYR PHARMA INC
12 May 2015
10% owner
Bought
25,000
$350.00K
10.8%
AXGN Axogen, Inc.
8 Apr 2015
10% owner
Sold, plan not stated
144,385
$469.25K
3.7%
EHTH eHealth, Inc.
6 Mar 2015
10% owner
Bought
30,103
$286.58K
2.3%
EHTH eHealth, Inc.
14 Jan 2015
10% owner
Bought
553,000
$11.23M
44.2%
EHTH eHealth, Inc.
14 Jan 2015
10% owner
Bought
447,000
$9.08M
44.1%
VNDA Vanda Pharmaceuticals Inc.
23 Dec 2014
10% owner
Bought
90,080
$1.30M
5.7%
VNDA Vanda Pharmaceuticals Inc.
23 Dec 2014
10% owner
Bought
71,934
$1.04M
5.6%
TARA Protara Therapeutics, Inc.
27 Oct 2014
10% owner
Bought
469,495
$4.69M
115%
TARA Protara Therapeutics, Inc.
27 Oct 2014
10% owner
Bought
121,332
$1.21M
139%
TARA Protara Therapeutics, Inc.
27 Oct 2014
10% owner
Bought
100,886
$1.01M
145%
EHTH eHealth, Inc.
7 Aug 2014
10% owner
Bought
1,731
$36.44K
0.1%
EHTH eHealth, Inc.
7 Aug 2014
10% owner
Bought
1,400
$29.47K
0.1%
EHTH eHealth, Inc.
5 Aug 2014
10% owner
Bought
2,085
$43.76K
0.2%
EHTH eHealth, Inc.
5 Aug 2014
10% owner
Bought
1,685
$35.37K
0.2%
EHTH eHealth, Inc.
4 Aug 2014
10% owner
Bought
85,975
$1.78M
7.4%
EHTH eHealth, Inc.
4 Aug 2014
10% owner
Bought
69,495
$1.44M
7.4%
EHTH eHealth, Inc.
1 Aug 2014
10% owner
Bought
94,176
$1.80M
8.8%
EHTH eHealth, Inc.
1 Aug 2014
10% owner
Bought
76,124
$1.45M
8.8%
RIGL RIGEL PHARMACEUTICALS INC
26 May 2011
10% owner
Bought
301,424
$2.41M
10.4%
RIGL RIGEL PHARMACEUTICALS INC
26 May 2011
10% owner
Bought
229,252
$1.83M
11.2%
RIGL RIGEL PHARMACEUTICALS INC
26 May 2011
10% owner
Bought
72,800
$582.40K
10.6%
RIGL RIGEL PHARMACEUTICALS INC
26 May 2011
10% owner
Bought
46,524
$372.19K
11.0%
RIGL RIGEL PHARMACEUTICALS INC
3 Nov 2010
10% owner
Sold, plan not stated
3,690
$27.86K
0.1%
RIGL RIGEL PHARMACEUTICALS INC
3 Nov 2010
10% owner
Sold, plan not stated
2,605
$19.67K
0.1%
RIGL RIGEL PHARMACEUTICALS INC
3 Nov 2010
10% owner
Sold, plan not stated
900
$6.80K
0.1%
RIGL RIGEL PHARMACEUTICALS INC
3 Nov 2010
10% owner
Sold, plan not stated
516
$3.90K
0.1%
BGMS Bio Green Med Solution, Inc.
19 Nov 2008
10% owner
Sold, plan not stated
260,636
$65.13K
22.8%
BGMS Bio Green Med Solution, Inc.
19 Nov 2008
10% owner
Sold, plan not stated
128,157
$32.18K
20.3%
BGMS Bio Green Med Solution, Inc.
18 Nov 2008
10% owner
Sold, plan not stated
35,075
$15.51K
3.0%
BGMS Bio Green Med Solution, Inc.
18 Nov 2008
10% owner
Sold, plan not stated
19,389
$8.57K
3.0%
BGMS Bio Green Med Solution, Inc.
14 Nov 2008
10% owner
Sold, plan not stated
23,378
$11.46K
1.9%
BGMS Bio Green Med Solution, Inc.
14 Nov 2008
10% owner
Sold, plan not stated
12,922
$6.33K
1.9%
BGMS Bio Green Med Solution, Inc.
13 Nov 2008
10% owner
Sold, plan not stated
168,684
$82.62K
12.3%
BGMS Bio Green Med Solution, Inc.
13 Nov 2008
10% owner
Sold, plan not stated
93,246
$45.67K
12.3%
193 decisions on file.